Mallinckrodt plc announced that the FDA has on 11 March 2014 approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets...
The FDA has approved Quillivant XR (methylphenidate hydrochloride) from Next Wave Pharma for extended-release oral suspension for treatment of Attention...
The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed...
Veloxis Pharmaceuticals A/S announced that Envarsus XR (extended release tacrolimus) was granted Orphan Drug status by the U.S. Food and...
On 5th November 2010 the FDA approved Kombiglyze XR from BMS/AstraZeneca, for the treatment of type 2 diabetes in adults....
Pfizer has announced that the FDA has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment...
Veloxis Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking a new indication for Envarsus XR...
The FDA has informed Veloxis of the tentative approval of Envarsus XR (tacrolimus extended relief) for Transplant Rejection. The FDA...
AstraZeneca have announced that the FDA has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of...
Upsher-Smith Laboratories, Inc. has announced that it has received FDA approval of a supplemental new drug application (sNDA) for Qudexy XR...